Association of breastfeeding status with risk of autism spectrum disorder: A systematic review, dose-response analysis and meta-analysis

Ghozy, Sherief; Tran, Linh; Sattar, Naveed; Quynh, Tran Thuy Huong; Zayan, Ahmad Helmy; Waqas, Ahmed; Sayed, Ahmed Kamal; Karimzadeh, Sedighe; Hirayama, Kenji; Huy, Nguyen Tien

doi:10.1016/j.ajp.2019.101916

Cited by 51 publications

(48 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[40][41][42][43] although the evidence of these effects is inconclusive. 16,19,[44][45][46][47][48][49] Third, generalizability may be a concern, because the CD rate varies greatly between countries. 50 Our findings may only be generalizable to countries with similar settings where most CDs are performed in the presence of medical indications.…”

Section: Strengths and Limitationsmentioning

confidence: 99%

Assessment of Cesarean Delivery and Neurodevelopmental and Psychiatric Disorders in the Children of a Population-Based Swedish Birth Cohort

et al. 2021

View full text Add to dashboard Cite

show abstract

Section: Strengths and Limitationsmentioning

confidence: 99%

Assessment of Cesarean Delivery and Neurodevelopmental and Psychiatric Disorders in the Children of a Population-Based Swedish Birth Cohort

et al. 2021

View full text Add to dashboard Cite

show abstract

“…To ensure not missing any paper, a manual search was conducted after the systemic one using various methods, all relevant papers in PubMed and Google Scholar were checked, we searched into the references of papers included from the systemic search, and we also used relevant Mesh terms and keywords to check for missing papers. 41 , 42 Duplication between database results was removed using EndNote X8 software. Four authors independently reviewed search results from the title and the abstract considering our inclusion and exclusion criteria in a preformed excel sheet, all original papers reporting patients with PD and Covid‐19 were included.…”

Section: Methodsmentioning

confidence: 99%

The impact of Parkinson's disease on manifestations and outcomes of Covid‐19 patients: A systematic review and meta‐analysis

El‐Qushayri

Ghozy

Reda

et al. 2021

Reviews in Medical Virology

Self Cite

View full text Add to dashboard Cite

Summary Parkinson's disease (PD) patients who contracted Coronavirus disease 2019 (Covid‐19) had a decline in motor functions; nevertheless, there is limited evidence on whether PD patients have a higher risk for contracting Covid‐19 or have worse outcomes. This is the first systematic review and meta‐analysis to review the impact of PD on the prognosis of Covid‐19 patients. We performed a systematic search through seven electronic databases under the recommendations of the Preferred Reporting Items for Systematic Review and Meta‐analyses statement (PRISMA) guidelines. The R software version 4.0.2 was used to calculate pooled sample sizes and their associated confidence intervals (95%CI). Finally, we included 13 papers in this study. The pooled prevalence rate of Covid‐19 was 2.12% (95%CI: 0.75–5.98). Fever, cough, fatigue and anorexia were the most common symptoms with a rate of 72.72% (95% CI: 57.3 ‐ 92.29), 66.99% (95% CI: 49.08–91.42), 61.58% (95% CI: 46.69–81.21) and 52.55% (95% CI: 35.09–78.68), respectively. The pooled rates were 39.89% (95% CI: 27.09–58.73) for hospitalisation, 4.7% (95% CI: 1.56–14.16) for ICU admission and 25.1% (95%CI: 16.37–38.49) for mortality. On further comparison of hospitalisation and mortality rates among Covid‐19 patients with and without PD, there were no significant differences. In conclusion, the prevalence and prognosis of Covid‐19 patients seem comparable in patients with PD and those without it. The increased hospitalisation and mortality may be attributed to old age and co‐morbidities.

show abstract

“…This literature review is based on an extensive literature search in Medline, Cochrane, and EMBASE databases which was performed on 1st August 2021 using the medical subject headings (MeSH) or a combination of all possible related terms. 11,12 This was followed by the manual search for papers in Google Scholar while the reference lists of the initially included papers. 13,14 Papers discussing the effectiveness and safety of common immunomodulatory agents for CRPS were screened for relevant information, with no limitation on date, language, age of participants, or publication type.…”

Section: Methodsmentioning

confidence: 99%

Effectiveness and side effects of immunomodulatory agents for complex regional pain syndrome

Alshaer

Binobaid

Nanoh

et al. 2021

Int J Community Med Public Health

View full text Add to dashboard Cite

The main causes of Complex regional pain syndrome (CRPS) are not fully understood. However, it usually emerges following a surgery or an injury to a limb. Inflammation, musculoskeletal, neuronal, and microvascular abnormalities have been found to contribute to the progression of the disease. Immune cells activation, especially with regards to the early phases of the disease is also indicated in the literature. Accordingly, efforts were directed to manage and enhance such responses, aiming to enhance the outcomes by introducing many immunomodulatory agents for managing patients with CRPS and relieving the associated pain. In this literature review, we have discussed the effectiveness and safety of common immunomodulatory agents for CRPS. We have mainly reviewed the roles of glucocorticoids, TNF-α antagonists, bisphosphonates, and intravenous immunoglobulins administration. Glucocorticoids were among the first reported modalities in the management of the syndrome. However, their use is approached with caution because of their potential systemic side effects. Bisphosphonates and TNF-α antagonists also have validated efficacies and should be administered within the early inflammatory phases to achieve better outcomes. Intravenous immunoglobulins are not adequately validated among the current studies, and evidence shows that they might be useful for a certain subgroup. Therefore, further investigations are required to formulate stronger evidence.

show abstract

Association of breastfeeding status with risk of autism spectrum disorder: A systematic review, dose-response analysis and meta-analysis

Cited by 51 publications

References 47 publications

Assessment of Cesarean Delivery and Neurodevelopmental and Psychiatric Disorders in the Children of a Population-Based Swedish Birth Cohort

Assessment of Cesarean Delivery and Neurodevelopmental and Psychiatric Disorders in the Children of a Population-Based Swedish Birth Cohort

The impact of Parkinson's disease on manifestations and outcomes of Covid‐19 patients: A systematic review and meta‐analysis

Effectiveness and side effects of immunomodulatory agents for complex regional pain syndrome

Contact Info

Product

Resources

About